Comparison of Lormetazepam and Midazolam Used as Sedatives for Patients That Require Intensive Care
Status:
Completed
Trial end date:
2020-03-12
Target enrollment:
Participant gender:
Summary
A goal directed , demand-driven administration of sedative drugs is an integral part of every
intensive care treatment. During long-term application of sedatives, Midazolam is the most
commonly used sedative in Europe.
One major objective is the problem of oversedation and agitation during an intensive care
treatment due to the lack of controllability of available substances.
The Love-Mi RCT investigates the clinical controllability of Midazolam versus the newly
available intravenous drug Lormetazepam.
Phase:
Phase 4
Details
Lead Sponsor:
Claudia Spies
Treatments:
Hypnotics and Sedatives Lorazepam Lormetazepam Midazolam